Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Reyataz (Atazanavir)

The Basics | News & Research

See also: Medication Side Effects | Drug Interactions

Show Archived (Historical) Articles

Brand Name:	Reyataz
Generic Name:	Atazanavir, ATV
Adult Single Dose:	Therapy-naive patients: two 200-mg capsules (once a day) Therapy- experienced patients: two 150-mg capsules plus one 100-mg ritonavir capsule (once a day)
Food & Liquid Restrictions:	Take with food
Drug Class:	PI

From The Body's "Ask the Experts" Forums

I just started taking Truvada + Reyataz + Norvir, but there's a shortage of Reyataz in my country and I can't get the right dosage. Is it a problem that I'm taking 400mg of Reyataz instead of 300mg?
Reyataz is causing a yellowing of my skin and eyes; is there another drug I can take?
Can Reyataz reduce a person's tolerance for alcohol?

» More questions

The Basics

An Overview of Reyataz (Atazanavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
FAQs About Reyataz (Regularly Updated)
From The Body's "Ask the Experts" Forums
Patient Information About Reyataz (Atazanavir) (PDF) (April 2009)
From Bristol-Myers Squibb Company
Reyataz (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Atazanavir (Reyataz) (October 15, 2008)
To read PDF, click here
From AIDS InfoNet
Reyataz (Atazanavir) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Reyataz (Atazanavir) Package Insert Revisions (January 16, 2008)
From U.S. Food and Drug Administration
Atazanavir (Reyataz) (August 15, 2006)
From AIDS Treatment Data Network
Labeling Changes for Atazanavir (Reyataz) (January 26, 2006)
To read PDF, click here
From U.S. Food and Drug Administration

News & Research

Reyataz and Sustiva Co-Pay Benefit Program (April 16, 2009)
If you live in the U.S., you might be eligible for a benefits program created to help people who are already insured, but still need help to pay for Reyataz or Sustiva.
From Bristol-Myers Squibb Company
Warnings About Taking Reyataz With Sustiva, Viramune, Oral Contraceptives (August 21, 2008)
From U.S. Food and Drug Administration
Switch to Atazanavir Does Not Reduce Belly Fat (August 4, 2008)
From aidsmap.com
New Pediatric Dosing Recommendations for Reyataz Capsules, Patients Ages 6 to 18 Years Old (March 26, 2008)
To read PDF, click here
From U.S. Food and Drug Administration
Atazanavir Noninferior to Lopinavir in Treatment-Naive HIV-Infected People (February 6, 2008)
From The Body PRO
Reyataz Monotherapy Study Stopped (October 2007)
To read PDF, click here
In Project Inform Perspective, from Project Inform
ATAZIP: Switching Away From Lopinavir/Ritonavir (July 25, 2007)
Switching from lopinavir/ritonavir (Kaletra) to atazanavir (Reyataz)/ritonavir (Norvir) maintains virologic efficacy and leads to sustained improvements in lipid levels. Graeme Moyle, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
Bristol-Myers Squibb Receives FDA Approval for New Formulation of Antiretroviral Reyataz (October 24, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
New 300 mg Reyataz Capsule Approved (October 23, 2006)
From U.S. Food and Drug Administration
Increased I50L Prevalence Found After Unboosted Atazanavir Use in PI-Treatment-Experienced Patients (August 17, 2006)
In XVI International AIDS Conference
Switching From Lopinavir/Ritonavir to Unboosted Atazanavir May Yield Benefits, but Verdict Remains Uncertain (August 17, 2006)
In XVI International AIDS Conference
Acid-Reducing Agents Reduce Atazanavir Drug Levels but Not Lopinavir/Ritonavir Levels (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Pharmacokinetic Data Show That Fosamprenavir + Atazanavir Combination Should Not Be Used (February 6, 2006)
However, boosting with atazanavir instead of ritonavir does appear feasible, this study finds.
In The 13th Conference on Retroviruses and Opportunistic Infections
Atazanavir, With or Without Ritonavir, Should Not Be Coadministered With Proton Pump Inhibitors (December 20, 2004)
From U.S. Food and Drug Administration
New Dosing Regimen for Ritonavir-Boosted Atazanavir in Treatment-Experienced Patients; Revisions Made to Packaging Insert (July 7, 2004)
From U.S. Food and Drug Administration
Atazanavir/Tenofovir Combo Should Be Boosted With Ritonavir (August 8, 2003)
From U.S. Food and Drug Administration

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.